Clicky

LivaNova PLC(LIVN)

Description: LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.


Keywords: Medicine Surgery Medical Equipment Healthcare Providers Prosthetics Cardiology Depression Heart Failure Cardiac Surgery Obstructive Sleep Apnea Therapeutic Solutions Repair Products Cardiopulmonary Bypass Drug Resistant Epilepsy Artificial Heart Valve

Home Page: www.livanova.com

LIVN Technical Analysis

20 Eastbourne Terrace
London, W2 6LG
United Kingdom
Phone: 44 20 3325 0660


Officers

Name Title
Mr. Damien McDonald CEO & Director
Mr. Alex Shvartsburg Chief Financial Officer
Ms. Trui Hebbelinck Chief HR Officer
Ms. Keyna Pidcock Skeffington Sr. VP, Special Advisor & Exec. Officer
Mr. Marco Dolci Pres of Cardiopulmonary Bus. Unit
Lindsey Little Sr. Director of Investor Relations
Mr. Michael Hutchinson Sr. VP, Chief Legal Officer and Company Sec.
Deanna Wilke VP of Corp. Communications
Mr. Matthew Joseph Dodds III Sr. VP of Corp. Devel.
Dr. Bryan D. Olin Ph.D. Sr. VP & Head of Product Devel. - Neuromodulation

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 24.4499
Trailing PE: 0
Price-to-Book MRQ: 2.588
Price-to-Sales TTM: 2.8203
IPO Date: 1993-02-10
Fiscal Year End: December
Full Time Employees: 3000
Back to stocks